BMO Capital lowered the firm’s price target on Nucor to $200 from $210 and keeps a Market Perform rating on the shares after its Q1 earnings miss. Following nine consecutive quarters of beating expectations, Nucor’s results and outlook disappointed, while its Q2 results are also expected to moderate sequentially, the analyst tells investors in a research note. Nucor remains well-positioned to benefit from positive longer-term demand tailwinds, but its capex spending elevated, BMO adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUE:
- NUE Earnings: Nucor Stock Down on Mixed Q1 Results and Weak Outlook
- Nucor Corp Unveils Strategic Insights in Investor Update
- Nucor falls 6% to $180 after Q1 results miss estimates
- Nucor Reports Results for the First Quarter of 2024
- Nucor expects Q2 earnings to decrease compared to Q1, consensus $3.63